Teva Pharmaceutical Industries Limited (TEVA)
Company Info
US8816242098
881624209
Mar 26, 1990
Highlights
$18.91B
-$0.85
1.29
$16.78B
$8.37B
$2.03B
$9.35 - $19.31
$22.36
1.61%
3.50
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Teva Pharmaceutical Industries Limited, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
Teva Pharmaceutical Industries Limited had a return of 67.91% year-to-date (YTD) and 74.78% in the last 12 months. Over the past 10 years, Teva Pharmaceutical Industries Limited had an annualized return of -10.54%, while the S&P 500 had an annualized return of 11.32%, indicating that Teva Pharmaceutical Industries Limited did not perform as well as the benchmark.
TEVA
67.91%
-4.99%
5.41%
74.78%
12.33%
-10.54%
^GSPC (Benchmark)
26.84%
5.60%
14.34%
32.39%
14.23%
11.32%
Monthly Returns
The table below presents the monthly returns of TEVA, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | 15.90% | 8.68% | 7.30% | -0.43% | 20.50% | -4.02% | 7.26% | 8.26% | -4.50% | 2.33% | -9.00% | 67.91% | |
| 2023 | 15.57% | -5.98% | -10.70% | -1.36% | -17.53% | 4.58% | 11.55% | 16.19% | 4.51% | -15.88% | 14.45% | 6.31% | 14.47% |
| 2022 | 5.24% | -3.56% | 15.50% | -7.24% | 4.48% | -17.36% | 24.73% | -3.62% | -10.73% | 10.53% | -1.68% | 3.99% | 13.86% |
| 2021 | 22.07% | -8.66% | 7.25% | -7.28% | -2.80% | -4.81% | -2.53% | -2.38% | 3.40% | -10.27% | -5.61% | -2.91% | -16.99% |
| 2020 | 6.12% | 10.87% | -22.12% | 19.60% | 16.67% | -1.60% | -6.41% | -14.47% | -8.71% | -3.22% | 9.06% | 1.47% | -1.53% |
| 2019 | 28.73% | -15.21% | -6.83% | -2.93% | -43.17% | 6.71% | -14.08% | -12.99% | -0.29% | 18.46% | 27.85% | -5.95% | -36.45% |
| 2018 | 7.70% | -8.28% | -8.71% | 5.21% | 19.58% | 13.12% | -1.56% | -4.30% | -5.98% | -7.24% | 7.81% | -28.41% | -18.63% |
| 2017 | -7.78% | 5.76% | -8.37% | -1.59% | -11.78% | 20.71% | -3.16% | -50.44% | 10.97% | -21.59% | 8.06% | 27.87% | -45.96% |
| 2016 | -6.34% | -9.02% | -3.76% | 1.76% | -4.10% | -3.16% | 6.51% | -5.21% | -8.69% | -7.11% | -11.79% | -2.97% | -43.20% |
| 2015 | -1.13% | 0.90% | 9.26% | -3.02% | 0.03% | -1.66% | 16.79% | -6.22% | -12.34% | 4.84% | 6.94% | 4.31% | 16.73% |
| 2014 | 11.35% | 12.62% | 5.91% | -7.53% | 4.06% | 3.82% | 2.06% | -1.17% | 2.34% | 5.06% | 1.45% | 0.93% | 47.36% |
| 2013 | 1.74% | -0.74% | 6.10% | -3.50% | 0.56% | 2.62% | 1.28% | -2.95% | -1.15% | -1.83% | 10.84% | -1.67% | 10.91% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current risk-adjusted rank of TEVA is 90, placing it in the top 10% of stocks on our website in terms of risk-adjusted performance. This ranking is based on the combined values of the indicators listed below.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Teva Pharmaceutical Industries Limited (TEVA) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Teva Pharmaceutical Industries Limited provided a 0.00% dividend yield over the last twelve months, with an annual payout of $0.00 per share.
| Period | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.85 | $1.36 | $1.36 | $1.37 | $1.28 |
Dividend yield | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 4.49% | 3.75% | 2.07% | 2.38% | 3.19% |
Monthly Dividends
The table displays the monthly dividend distributions for Teva Pharmaceutical Industries Limited. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2023 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2022 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2021 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2020 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2019 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2018 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2017 | $0.00 | $0.34 | $0.00 | $0.00 | $0.00 | $0.34 | $0.00 | $0.09 | $0.00 | $0.00 | $0.09 | $0.00 | $0.85 |
| 2016 | $0.00 | $0.34 | $0.00 | $0.00 | $0.34 | $0.00 | $0.00 | $0.34 | $0.00 | $0.00 | $0.00 | $0.34 | $1.36 |
| 2015 | $0.00 | $0.34 | $0.00 | $0.00 | $0.34 | $0.00 | $0.00 | $0.34 | $0.00 | $0.00 | $0.34 | $0.00 | $1.36 |
| 2014 | $0.00 | $0.35 | $0.00 | $0.00 | $0.35 | $0.00 | $0.00 | $0.35 | $0.00 | $0.00 | $0.32 | $0.00 | $1.37 |
| 2013 | $0.31 | $0.00 | $0.00 | $0.32 | $0.00 | $0.00 | $0.32 | $0.00 | $0.00 | $0.33 | $0.00 | $1.28 |
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Worst Drawdowns
The table below displays the maximum drawdowns of the Teva Pharmaceutical Industries Limited. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Teva Pharmaceutical Industries Limited was 90.80%, occurring on Aug 15, 2019. The portfolio has not yet recovered.
The current Teva Pharmaceutical Industries Limited drawdown is 73.83%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -90.8% | Jul 28, 2015 | 1021 | Aug 15, 2019 | — | — | — |
| -52% | Jun 23, 1997 | 265 | Jul 10, 1998 | 371 | Dec 29, 1999 | 636 |
| -43.99% | Mar 24, 2010 | 381 | Sep 23, 2011 | 783 | Nov 4, 2014 | 1164 |
| -36.47% | May 15, 1996 | 64 | Aug 14, 1996 | 95 | Dec 30, 1996 | 159 |
| -36.18% | Feb 25, 1994 | 220 | Jan 10, 1995 | 66 | Apr 13, 1995 | 286 |
Volatility
Volatility Chart
The current Teva Pharmaceutical Industries Limited volatility is 10.85%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
Historical P/E Ratio Chart
The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Teva Pharmaceutical Industries Limited.
Loading data...
Income Statement
| TTM | |
|---|---|
Revenue | |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |